EP3154559
USE OF SERELAXIN TO REDUCE GDF-15
:
EP einkaleyfi: Þýðing ekki lögð inn:
10.6.2015:
1.9.2021:
15730858.6
:
9.6.2035
:
USE OF SERELAXIN TO REDUCE GDF-15
10.6.2015
1.9.2021
:
Novartis AG:
Lichtstrasse 35, 4056 Basel, CH
:
PRESCOTT, Margaret Forney:
East Hanover, New Jersey 07936-1080, US
:
ZHANG, Yiming:
East Hanover, New Jersey 07936-1080, US
:
DAHLKE, Marion:
CH-4056 Basel, CH
:
SEVERIN, Thomas:
4056 Basel, CH
:
201462011744 P:
13.6.2014:
US
:
IB2015054399:
10.6.2015
:
A61K 38/00, A61K 38/22, A61B 5/00, A61P 9/00, A61P 11/00, A61P 9/04